Showing 101-110 of 5594 results for "".
From Infusion Chair to Clinic Visit: How Subcutaneous Nivolumab May Simplify RCC Care
https://reachmd.com/programs/project-oncology/from-infusion-chair-to-clinic-visit-how-subcutaneous-nivolumab-may-simplify-rcc-care/36399/Implementing the 2021 Updates to Office Visit Evaluation & Management Documentation, Coding, & Billing Requirements
https://reachmd.com/programs/perspectives-ama/implementing-the-2021-updates-to-office-visit-evaluation-management-documentation-coding-billing/11998/Here’s the inside scoop on the latest Evaluation and Management code changes for 2021 as well as currently available resources.Promising results for APOC3 ASO in familial chylomicronemia syndrome
https://reachmd.com/programs/acc-action-center/promising-results-for-apoc3-aso-in-familial-chylomicronemia-syndrome/24309/ACC.24 - Results of the Balance trial showed that the APOC3 ASO olezarsen reduces triglycerides in patients with familial chylomicronemia syndrome (FCS). The data of the secondary outcome of new-onset pancreatitis were quite astonishing, according to Erik Stroes.Mitigating the Opioid Epidemic in Pregnant Women and Newborn Infants on a Shoestring Budget
https://reachmd.com/programs/lifelong-learning/mitigating-the-opioid-epidemic-in-pregnant-women-and-newborn-infants-on-a-shoestring-budget/10021/Dr. Camille Fung reviews the unaddressed public health problem of opioid management in pregnant women and newborn infants with NAS.Anthrax: The Natural Born Killer
https://reachmd.com/programs/clinicians-roundtable/anthrax-the-natural-born-killer/1363/Anthrax. Thought to be the sixth plague visited upon Pharoah in the Book of Exodus, the disease only causes episodic illness in humans. Yet it can cause a particularly gruesome death and can be easily treated if caught early. Our guest, Doctor Nicholas Bergman, explores the biology of naturally oThoughts on Physician Advocacy and Payment Reform with AMA Past-President Andrew Gurman, MD
https://reachmd.com/programs/perspectives-ama/thoughts-physician-advocacy-payment-reform--ama-past-president-andrew-gurman-md/8183/Previously recorded in 2016 - For current information on MACRA, please visit reachmd.com/amaMACRA Issues for Physicians in Small Practices
https://reachmd.com/programs/perspectives-ama/macra-issues-physicians-small-practices/8560/Previously recorded in 2016 - For current information on MACRA, please visit reachmd.com/amaHighlights from Day 3 of ACC.23
https://reachmd.com/programs/acc-action-center/highlights-day-3-acc23/15067/What did we learn from the last day of the American College of Cardiology's Scientific Session & Expo? Find out.CAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment
https://reachmd.com/programs/living-rheum/car-t-cell-therapy-new-frontiers-in-diffuse-systemic-sclerosis-treatment/30073/CD19-targeted CAR T-cell therapy may offer lasting benefits for diffuse systemic sclerosis. Here’s what you should know.The National Children’s Study: Essentials
https://reachmd.com/programs/focus-on-future-medicine-and-genetics/the-national-childrens-study-essentials/4011/The National Children’s Study will follow the health and development of more than 100,000 children across the United States, starting from before birth until age 21. What do you need to know about this ambitious federally financed project? Dr. Peter Scheidt, medical officer and co-director of the Na